AP-1 confers resistance to anti-cancer therapy by activating XIAP

por Wang, Yuan, Wan, Guo-Hui, Wu, Ying-Min, Wang, Hong-Sheng, Wang, Hai-Fang, Zhang, Ge, Lu, Lin-Lin, Li, Zi-Qian, Chan, Ka-Ying, Zhou, Yan, Cai, Shao-Hui, Qi, Yi-Fei, Du, Jun
Publicado 2018